Navigation Links
Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014
Date:7/22/2014

Los Angeles, CA (PRWEB) July 22, 2014

Holomic is expanding its portfolio of rapid test solutions with the debut of its fluorescent immunoassay reader, the HRDR-300, at the American Association of Clinical Chemistry (AACC) meeting in Chicago, July 28-31, 2014. Available in both portable Smartphone based or bench top versions, the HRDR-300 is a highly sensitive, low-cost fluorescent reader that uses patent pending technology to analyze fluorescent lateral flow immunoassays with high sensitivity and accuracy.

The HRDR-300 provides a comprehensive rapid test solution to manufacturers and end-users of fluorescent tests. For manufacturers, the HRDR-300 fluorescent reader can be used as a universal reader for tests of all formats and sizes and at prices that compete with similar bench top instruments in the market. Coupled with Holomic’s ‘Test Developer', rapid test vendors can obtain deeper insight into the performance of their tests and create reader calibration files for download by end users.

Other features include test and lot number identification as well as test and patient data retrieval from bar/QR codes. The reader has lab and field applications with connectivity to a secure CLOUD server for remote data access and analytics as well as EHR and LIS integration.

The HRDR-300 is a key addition to Holomics portfolio of rapid test solutions that already comprises of chromatographic readers and software and data management solutions. With a suite of reader products, the company has developed customized reader solutions for the clinic/home-use, global health and lateral flow immunoassay manufacturing markets. The HRDR-300 is compliant with ISO13485 and is registered with the FDA as a Class 1 medical device. Visit http://www.holomic.com for more information.

Holomic will showcase the HRDR-300 and other rapid test solutions at the AACC meeting in Chicago at booth #2043, July 29-31, 2014. Holomic will also exhibit the same at Medica in Dusseldorf, November 12-15, 2014. Contact Ketaki Sood, Director of Product Marketing, ketaki(at)holomic(dot)com, 310.443.2070, http://www.holomic.com.

The HRDR-300 is available for sale globally. In the US, it is available for Research Use Only. Not for use in diagnostic procedures.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12027542.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
2. Tianli-Xiduhei(TM) Black Pork Meat Makes Official Debut in Beijing Food Stores
3. Leica Microsystems Debuts First 3D Surgical Microscopes with TrueVision® Technology Inside, at AANS Annual Meeting in New Orleans
4. PathoGenetix to Debut New Genotyping Technology for Rapid Strain Typing at IAFP
5. SoundConnect Debuts on Inc. 5000 List of Fastest Growing Companies
6. Neurophotonics to debut at SPIE Photonics Europe 2014
7. Bayer CropScience Debuts Serenade Optimum to Help Growers Control Tough Diseases and Combat Resistance
8. JCB Laboratories Debuts High Tech Monitoring System That Will Further Enhance Patient Safety, Surpass Compounding Pharmacy Standards
9. ATCC Announces Agreement with Life Technologies Corporation to Sell and Distribute Green Fluorescent Protein (GFP)-based Materials
10. Goodbye, fluorescent light bulbs! See your office in a new light
11. Research on China's FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):